• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    11/11/22 12:07:49 PM ET
    $ACEV
    $ACST
    $ADIL
    $AGRI
    Semiconductors
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACEV alert in real time by email

     

    On Friday, 63 stocks hit new 52-week lows.

    Interesting Points From Today's 52-Week Lows:

    • Algonquin Power (NYSE:AQN) was the biggest company in terms of market cap to set a new 52-week low.
    • The smallest company on a market cap basis to set a new 52-week low was First Wave BioPharma (NASDAQ:FWBI).
    • Blue Apron Hldgs (NYSE:APRN)'s stock came under the most pressure, trading down 29.9% to reach a new 52-week low.
    • Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    The stocks that set new 52-week lows on Friday:

    • Algonquin Power (NYSE:AQN) shares hit a yearly low of $9.28. The stock was down 14.9% on the session.
    • Agiliti (NYSE:AGTI) shares moved down 5.68% on Friday to hit a new 52-week low of $14.20, drifting down 5.68%.
    • EverCommerce (NASDAQ:EVCM) stock hit a yearly low of $6.01. The stock was down 20.72% for the day.
    • FIGS (NYSE:FIGS) shares reached a new 52-week low of $5.55 on Friday morning, moving down 2.59%.
    • Expensify (NASDAQ:EXFY) shares were down 21.0% for the day, having made a 52-week low of $8.61.
    • Arco Platform (NASDAQ:ARCE) stock achieved a new 52-week low on Friday morning, hitting $9.84 and moving down 4.1%.
    • Trevena (NASDAQ:TRVN) stock achieved a new 52-week low on Friday morning, hitting $2.38 and moving up 0.81%.
    • SoundHound AI (NASDAQ:SOUN) shares made a new 52-week low of $1.77 on Friday. The stock was down 0.45% for the day.
    • Largo (NASDAQ:LGO) shares reached a new 52-week low of $4.84 on Friday morning, moving up 3.47%.
    • Tattooed Chef (NASDAQ:TTCF) shares fell to $3.22 on Friday, setting a new 52-week low with a shift of down 15.47%.
    • Global Business Travel (NYSE:GBTG) shares fell to $4.90 on Friday, setting a new 52-week low with a shift of down 7.09%.
    • Arbe Robotics (NASDAQ:ARBE) stock broke to a new 52-week low of $4.18 on Friday. Shares of the company traded down 0.23%.
    • Tritium DCFC (NASDAQ:DCFC) stock broke to a new 52-week low of $1.57 on Friday. Shares of the company traded up 1.86%.
    • The Oncology Institute (NASDAQ:TOI) stock set a new 52-week low of $2.45 on Friday, moving down 12.07%.
    • AirSculpt Technologies (NASDAQ:AIRS) stock hit a new 52-week low of $3.23. The stock was down 29.28% on the session.
    • Rallybio (NASDAQ:RLYB) shares reached a new 52-week low of $4.86 on Friday morning, moving down 18.51%.
    • Bitfarms (NASDAQ:BITF) shares reached a new 52-week low of $0.68 on Friday morning, moving up 1.18%.
    • Science 37 Hldgs (NASDAQ:SNCE) shares set a new 52-week low of $0.82. The stock traded down 21.6%.
    • ACE Convergence Acq (NASDAQ:ACEV) shares set a new 52-week low of $8.90. The stock traded down 1.26%.
    • Kaixin Auto Hldgs (NASDAQ:KXIN) stock hit a yearly low of $0.43. The stock was down 6.08% for the day.
    • ThredUp (NASDAQ:TDUP) stock hit $0.73 on Friday morning, setting a new 52-week low for a change of up 4.47%.
    • Jounce Therapeutics (NASDAQ:JNCE) shares set a new 52-week low of $1.11. The stock traded up 5.98%.
    • XWELL (NASDAQ:XWEL) shares made a new 52-week low of $0.54 on Friday. The stock was up 1.18% for the day.
    • East Stone Acq (NASDAQ:ESSC) shares reached a new 52-week low of $6.99 on Friday morning, moving down 29.56%.
    • Pyxis Oncology (NASDAQ:PYXS) stock hit a yearly low of $1.38. The stock was down 2.82% for the day.
    • Blue Apron Hldgs (NYSE:APRN) shares set a new 52-week low of $1.17. The stock traded down 29.9%.
    • BioLine Rx (NASDAQ:BLRX) shares hit a yearly low of $0.57. The stock was up 0.48% on the session.
    • Redhill Biopharma (NASDAQ:RDHL) shares set a new 52-week low of $0.45. The stock traded down 17.55%.
    • LightPath Technologies (NASDAQ:LPTH) shares fell to $0.99 on Friday, setting a new 52-week low with a shift of up 5.88%.
    • Aprea Therapeutics (NASDAQ:APRE) shares set a new 52-week low of $0.41. The stock traded down 16.67%.
    • Acasti Pharma (NASDAQ:ACST) shares set a new yearly low of $0.48 this morning. The stock was down 1.77% on the session.
    • China Natural Resources (NASDAQ:CHNR) shares set a new yearly low of $0.42 this morning. The stock was down 1.88% on the session.
    • Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares were 0.0% (flat) for the day, having made a 52-week low of $1.68.
    • Vapotherm (NYSE:VAPO) shares were up 0.15% for the day, having made a 52-week low of $0.58.
    • AgriFORCE Growing Systems (NASDAQ:AGRI) shares set a new 52-week low of $0.95. The stock traded up 2.01%.
    • PLx Pharma (NASDAQ:PLXP) stock hit a new 52-week low of $0.41. The stock was down 23.33% on the session.
    • Venus Concept (NASDAQ:VERO) shares moved down 4.06% on Friday to hit a new 52-week low of $0.20, drifting down 4.06%.
    • Reed's (NASDAQ:REED) stock hit $0.11 on Friday morning, setting a new 52-week low for a change of down 7.03%.
    • NexImmune (NASDAQ:NEXI) stock broke to a new 52-week low of $0.48 on Friday. Shares of the company traded 0.0% (flat).
    • BIO-key Intl (NASDAQ:BKYI) stock hit $1.34 on Friday morning, setting a new 52-week low for a change of down 2.37%.
    • Kazia Therapeutics (NASDAQ:KZIA) shares hit a yearly low of $0.65. The stock was up 0.01% on the session.
    • Ayala Pharmaceuticals (NASDAQ:AYLA) stock achieved a new 52-week low on Friday morning, hitting $0.55 and moving up 0.33%.
    • Arcadia Biosciences (NASDAQ:RKDA) shares hit a yearly low of $0.30. The stock was down 5.75% on the session.
    • OncoSec Medical (NASDAQ:ONCS) stock achieved a new 52-week low on Friday morning, hitting $3.96 and moving down 12.02%.
    • Phio Pharma (NASDAQ:PHIO) shares reached a new 52-week low of $0.51 on Friday morning, moving down 1.87%.
    • Trxade Health (NASDAQ:MEDS) shares set a new 52-week low of $0.70. The stock traded up 7.19%.
    • Adial Pharmaceuticals (NASDAQ:ADIL) stock broke to a new 52-week low of $0.24 on Friday. Shares of the company traded up 0.56%.
    • Kintara Therapeutics (NASDAQ:KTRA) shares fell to $0.08 on Friday, setting a new 52-week low with a shift of down 18.54%.
    • Healthcare Triangle (NASDAQ:HCTI) stock hit $0.16 on Friday morning, setting a new 52-week low for a change of down 8.15%.
    • NeuBase Therapeutics (NASDAQ:NBSE) shares moved down 1.06% on Friday to hit a new 52-week low of $0.18, drifting down 1.06%.
    • Quotient (NASDAQ:QTNT) stock broke to a new 52-week low of $1.54 on Friday. Shares of the company traded down 10.9%.
    • Viveve Medical (NASDAQ:VIVE) stock dropped to a yearly low on Friday of $0.47. Shares traded down 6.65%.
    • Cuentas (NASDAQ:CUEN) shares reached a new 52-week low of $0.30 on Friday morning, moving down 5.0%.
    • Schmitt Industries (NASDAQ:SMIT) stock hit a new 52-week low of $0.81. The stock was down 10.2% on the session.
    • Energy Focus (NASDAQ:EFOI) stock drifted down 4.38% on Friday morning to hit a new 52-week low of $0.32.
    • First Wave BioPharma (NASDAQ:FWBI) shares reached a new 52-week low of $0.85 on Friday morning, moving 0.0% (flat).

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACEV
    $ACST
    $ADIL
    $AGRI

    CompanyDatePrice TargetRatingAnalyst
    LightPath Technologies Inc.
    $LPTH
    1/29/2026$15.00Buy
    Canaccord Genuity
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    Algonquin Power & Utilities Corp.
    $AQN
    1/7/2026$7.50Sector Perform → Outperform
    National Bank Financial
    EverCommerce Inc.
    $EVCM
    1/5/2026$12.00Outperform → Sector Perform
    RBC Capital Mkts
    Algonquin Power & Utilities Corp.
    $AQN
    12/16/2025Sector Perform → Sector Outperform
    Scotiabank
    SoundHound AI Inc
    $SOUN
    12/12/2025$15.00Neutral → Overweight
    Cantor Fitzgerald
    The Oncology Institute Inc.
    $TOI
    11/25/2025$5.00Buy
    Needham
    Algonquin Power & Utilities Corp.
    $AQN
    11/10/2025Neutral → Buy
    Janney
    More analyst ratings

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lockshin Curtis was granted 16,600 shares, increasing direct ownership by 89% to 35,155 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    2/6/26 8:01:09 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Freeman Jonathan E was granted 16,600 shares, increasing direct ownership by 103% to 32,655 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    2/6/26 8:00:21 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Deming David H was granted 23,800 shares, increasing direct ownership by 170% to 37,800 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    2/6/26 7:59:20 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACEV
    $ACST
    $ADIL
    $AGRI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for APHEXDA issued to BIOLINERX, LTD.

    Submission status for BIOLINERX, LTD.'s drug APHEXDA (ORIG-1) with active ingredient MOTIXAFORTIDE has changed to 'Approval' on 09/08/2023. Application Category: NDA, Application Number: 217159, Application Classification: Type 1 - New Molecular Entity

    9/11/23 2:15:50 PM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACEV
    $ACST
    $ADIL
    $AGRI
    SEC Filings

    View All

    SEC Form 6-K filed by Bitfarms Ltd.

    6-K - Bitfarms Ltd (0001812477) (Filer)

    2/6/26 5:08:22 PM ET
    $BITF
    Finance: Consumer Services
    Finance

    SEC Form S-8 POS filed by Venus Concept Inc.

    S-8 POS - Venus Concept Inc. (0001409269) (Filer)

    2/6/26 4:47:21 PM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Venus Concept Inc.

    S-8 POS - Venus Concept Inc. (0001409269) (Filer)

    2/6/26 4:47:21 PM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on LightPath with a new price target

    Canaccord Genuity initiated coverage of LightPath with a rating of Buy and set a new price target of $15.00

    1/29/26 7:01:51 AM ET
    $LPTH
    Semiconductors
    Technology

    Bitfarms downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Bitfarms from Outperform to Mkt Perform and set a new price target of $3.00

    1/27/26 8:40:33 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Algonquin Power & Utilities upgraded by National Bank Financial with a new price target

    National Bank Financial upgraded Algonquin Power & Utilities from Sector Perform to Outperform and set a new price target of $7.50

    1/7/26 8:42:57 AM ET
    $AQN
    Electric Utilities: Central
    Utilities

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President/CEO Gilad Oren bought $25,009 worth of shares (28,100 units at $0.89), increasing direct ownership by 8% to 373,720 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:08:08 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $5,073 worth of shares (5,700 units at $0.89), increasing direct ownership by 21% to 33,433 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:05:34 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman, Pres. & CEO Bitterman Robert J bought $5,150 worth of shares (5,000 units at $1.03), increasing direct ownership by 2% to 291,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    1/2/26 4:05:06 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan

    PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today announced that it will effect a 1-for-60 reverse stock split of its common stock. The reverse stock split will become effective at 12:01 a.m. Eastern Time on Tuesday, February 10, 2026, and the Company's common stock will commence trading on the Nasdaq Capital Market on a post-split basis at the opening of the market on February 10, 2026, pending confirmation by the Depository Trust Company and the Nasdaq. The Company

    2/6/26 10:19:00 AM ET
    $HCTI
    EDP Services
    Technology

    Multi-Billion-Dollar VRU Detection Market Unlocking New Growth Opportunities

    Advanced radar-based safety technology gains traction across automotive and smart-city markets NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Market News Updates News Commentary - The Vulnerable Road User (VRU) RF sensing platform market is gaining momentum as road safety becomes a top priority for governments, automakers, and smart-city developers. These platforms use radio-frequency technologies like radar and mmWave sensing to detect pedestrians, cyclists, and other at-risk road users—often performing better than cameras in poor weather or low-light conditions. As vehicles become more automated and cities invest in smarter infrastructure, RF-based VRU sensing is increasingly viewed as a must-have

    2/6/26 8:50:00 AM ET
    $ADI
    $ARBE
    $NXPI
    Semiconductors
    Technology
    EDP Services
    Computer Software: Prepackaged Software

    Bitfarms Announces U.S. Redomiciliation Plan and Intent to Rebrand as Keel Infrastructure

    TORONTO, Ontario and NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX:BITF) ("Bitfarms" or the "Company"), a North American digital infrastructure and energy company, today announced that its Board of Directors has approved a plan of arrangement (the "Arrangement") under which the Company will redomicile from Canada to the United States (the "US Redomiciliation"), subject to receipt of shareholder, stock exchange and court approvals. The Arrangement is the culmination of a comprehensive strategic review process undertaken by the Board over the past 12 months, including ongoing analysis of investor sentiment and capital markets trends to identify opportunities to enhan

    2/6/26 7:00:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Leadership Updates

    Live Leadership Updates

    View All

    Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor

    DOYLESTOWN, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies that exploit cancer-specific vulnerabilities while minimizing damage to healthy cells, today announced the appointment of Eugene (Gene) Kennedy, MD, as Chief Medical Advisor. Dr. Kennedy joins Aprea at an important time, following the Company's recent early clinical proof-of-concept demonstrated in its ongoing Phase 1 dose-escalation study evaluating the WEE1 inhibitor APR-1051 in patients with advanced solid tumors. He is a highly accomplished physician scientist and biopharmaceutical executive wit

    2/4/26 8:30:00 AM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity

    BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a leadership transition to continue execution and advancement of the Company's strategic and clinical goals. Thomas Civik, a member of Pyxis Oncology's Board of Directors since the Company's IPO and a highly experienced biotechnology executive with a proven track record in advancing cancer therapeutics, has been appointed Interim Chief Executive Officer, effective immediately. Lara S. Sullivan, M.D., has stepped down from her roles as President, Chief Executive Officer and Chief Medical Officer. With

    2/3/26 6:45:00 AM ET
    $PYXS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference

    Phio's Presentation to take place on Wednesday January 28, 2026 at 9 AM ETKing of Prussia, Pennsylvania--(Newsfile Corp. - January 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026 at the Borgata Hotel in Atlantic City, NJ.Robert Bitterman, CEO and Chairman of the Board of Phio Pharmaceuticals will deliver a company presentation on January 28th at 9 AM in Borgata Hotel Room #1 and the management team will be avai

    1/26/26 8:15:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/4/24 6:11:30 AM ET
    $REED

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Financials

    Live finance-specific insights

    View All

    Algonquin Power & Utilities Corp. Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

    Algonquin Power & Utilities Corp. (TSX/NYSE:AQN) ("AQN") today announced plans to release its fourth quarter and full year 2025 financial results on Friday, March 6, 2026, before market open. AQN will hold an earnings conference call at 8:30 a.m. eastern time on Friday, March 6, 2026, hosted by Chief Executive Officer, Rod West, and Chief Financial Officer, Rob Stefani. Conference call details are as follows: Date: Friday, March 6, 2026 Time: 8:30 a.m. ET Conference Call: Toll Free Dial-In Number 1 800 715-9871   Toll Dial-In Number 1 646 307-1963   Conference ID 3922090 Webcast: https://edge

    2/6/26 6:30:00 AM ET
    $AQN
    Electric Utilities: Central
    Utilities

    FIGS Announces Date of Fourth Quarter and Full Year 2025 Earnings Release, Conference Call and Webcast

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a fourth quarter and full year 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS Fourth Quarter and Full Year 2025 Earnings and Conference Call

    2/5/26 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    LightPath Technologies to Host Second Quarter Fiscal 2026 Earnings Call on February 11 at 5:00 p.m. Eastern Time

    ORLANDO, Fla., Feb. 4, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced it will release financial results for the fiscal second quarter ended December 31, 2025 after market close on February 11, 2026. Management will host an investor conference call at 5:00 p.m. Eastern time on Wednesday, February 11, 2026 to discuss the Company's second quarter fiscal 2026 financial results, provide a corporate upd

    2/4/26 8:31:00 AM ET
    $LPTH
    Semiconductors
    Technology